Clinical Diagnostics: Global Markets
Report Scope:
This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.
An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).
For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.
Report Includes:
This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.
An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).
For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.
Report Includes:
- 22 data tables
- An up-to-date overview and analysis of the global clinical diagnostics market
- Analyses of the global market trends, with historic market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussion of the major growth drivers, opportunities and challenges, technology updates, and the impact of macroeconomic variables influencing the market for clinical diagnostics as a basis for projecting demand in the next few years (2023-2028)
- Estimation of the actual market size and revenue forecast for global clinical diagnostics market, and corresponding market share analysis based on the type of test, product and service, application, end user, and region
- In-depth information (facts and figures) concerning the major market dynamics, screening tools and techniques, regulatory developments, new and emerging technologies, and current competitive landscape of the clinical diagnostic market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Siemens Healthineers, Roche Diagnostics, Qiagen and Thermo Fisher Scientific Inc.
CHAPTER 1 INTRODUCTION
1.1 Improved Patient Outcomes
1.2 Improved Public Health
1.3 Reduced Healthcare Costs
1.4 Study Goals and Objectives
1.5 Reasons for Doing the Study
1.6 Scope of Report
1.7 Methodology and Information Sources
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
3.1 Overview
3.2 Quality Control
3.3 Quality Assurance
3.4 Turnaround Time
3.5 Clinical Correlation
3.6 Accuracy and Reliability
3.7 Patient Safety
3.7.1 Cancer Screening
3.7.2 Newborn Screening
3.7.3 Infectious Disease Screening
3.7.4 Cardiovascular Disease Screening
3.8 Types of Screening
3.9 Screening Tests
3.10 Screening Guidelines
3.11 Benefits of Screening
3.12 Limitations of Screening
3.13 Genetic Testing
3.14 Pharmacogenomics
3.15 Biomarker Testing
3.16 Proteomics
3.17 Metabolomics
CHAPTER 4 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY TYPE OF TEST
4.1 Introduction
4.1.1 Lipid Panels
4.1.2 Infectious Disease Testing
4.1.3 Complete Blood Count
4.1.4 Metabolic Panel Testing
4.1.5 Abnormal Metabolic Panel Results
4.1.6 Other Tests
CHAPTER 5 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY PRODUCT TYPE
5.1 Introduction
5.2 Assays and Kits
5.2.1 Types of Assays and Kits in Clinical Diagnostics
5.3 Instruments
5.3.1 Types of Instruments
5.4 Reagents
5.4.1 Types of Reagents
5.5 Software and Services
5.5.1 Data Management
CHAPTER 6 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY APPLICATION
6.1 Introduction
6.2 Infectious Diseases
6.3 Cancer
6.3.1 Types of Cancer
6.3.2 Causes of Cancer
6.3.3 Symptoms of Cancer
6.3.4 Diagnosis of Cancer
6.3.5 Treatment of Cancer
6.4 Cardiovascular Disease
CHAPTER 7 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY END USER
7.1 Introduction
7.2 Diagnostic Laboratories
7.3 Hospitals and Clinics
7.4 Other End Users
CHAPTER 8 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY REGION
8.1 Introduction
8.2 Global Market Size and Forecast
8.3 North America
8.3.1 United States
8.3.2 Canada
8.4 Europe
8.4.1 Germany
8.4.2 United Kingdom
8.5 Asia-Pacific
8.6 Rest of the World
CHAPTER 9 MARKET DYNAMICS
9.1 Market Drivers
9.1.1 Advances in Technology
9.1.2 Increasing Prevalence of Chronic and Infectious Diseases
9.1.3 Autoimmune Disorders
9.1.4 Aging Population
9.1.5 Rising Healthcare Expenditures
9.1.6 Point-of-Care Testing
9.1.7 Personalized Medicine
9.2 Market Challenges
9.2.1 Stringent Regulatory Scenario
9.2.2 Reimbursement Challenges
9.2.3 Increasing Market Competition
CHAPTER 10 EMERGING TECHNOLOGIES
10.1 Molecular Diagnostics
10.2 Next-Generation Sequencing (NGS)
10.3 Point-of-Care Testing
10.4 Artificial Intelligence (AI)
10.5 Other Emerging Techniques
CHAPTER 11 COMPETITIVE LANDSCAPE
11.1 Overview
CHAPTER 12 COMPANY PROFILES
ABBOTT LABORATORIES
BECTON, DICKINSON AND CO.
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
1.1 Improved Patient Outcomes
1.2 Improved Public Health
1.3 Reduced Healthcare Costs
1.4 Study Goals and Objectives
1.5 Reasons for Doing the Study
1.6 Scope of Report
1.7 Methodology and Information Sources
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
3.1 Overview
3.2 Quality Control
3.3 Quality Assurance
3.4 Turnaround Time
3.5 Clinical Correlation
3.6 Accuracy and Reliability
3.7 Patient Safety
3.7.1 Cancer Screening
3.7.2 Newborn Screening
3.7.3 Infectious Disease Screening
3.7.4 Cardiovascular Disease Screening
3.8 Types of Screening
3.9 Screening Tests
3.10 Screening Guidelines
3.11 Benefits of Screening
3.12 Limitations of Screening
3.13 Genetic Testing
3.14 Pharmacogenomics
3.15 Biomarker Testing
3.16 Proteomics
3.17 Metabolomics
CHAPTER 4 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY TYPE OF TEST
4.1 Introduction
4.1.1 Lipid Panels
4.1.2 Infectious Disease Testing
4.1.3 Complete Blood Count
4.1.4 Metabolic Panel Testing
4.1.5 Abnormal Metabolic Panel Results
4.1.6 Other Tests
CHAPTER 5 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY PRODUCT TYPE
5.1 Introduction
5.2 Assays and Kits
5.2.1 Types of Assays and Kits in Clinical Diagnostics
5.3 Instruments
5.3.1 Types of Instruments
5.4 Reagents
5.4.1 Types of Reagents
5.5 Software and Services
5.5.1 Data Management
CHAPTER 6 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY APPLICATION
6.1 Introduction
6.2 Infectious Diseases
6.3 Cancer
6.3.1 Types of Cancer
6.3.2 Causes of Cancer
6.3.3 Symptoms of Cancer
6.3.4 Diagnosis of Cancer
6.3.5 Treatment of Cancer
6.4 Cardiovascular Disease
CHAPTER 7 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY END USER
7.1 Introduction
7.2 Diagnostic Laboratories
7.3 Hospitals and Clinics
7.4 Other End Users
CHAPTER 8 CLINICAL DIAGNOSTICS MARKET BREAKDOWN BY REGION
8.1 Introduction
8.2 Global Market Size and Forecast
8.3 North America
8.3.1 United States
8.3.2 Canada
8.4 Europe
8.4.1 Germany
8.4.2 United Kingdom
8.5 Asia-Pacific
8.6 Rest of the World
CHAPTER 9 MARKET DYNAMICS
9.1 Market Drivers
9.1.1 Advances in Technology
9.1.2 Increasing Prevalence of Chronic and Infectious Diseases
9.1.3 Autoimmune Disorders
9.1.4 Aging Population
9.1.5 Rising Healthcare Expenditures
9.1.6 Point-of-Care Testing
9.1.7 Personalized Medicine
9.2 Market Challenges
9.2.1 Stringent Regulatory Scenario
9.2.2 Reimbursement Challenges
9.2.3 Increasing Market Competition
CHAPTER 10 EMERGING TECHNOLOGIES
10.1 Molecular Diagnostics
10.2 Next-Generation Sequencing (NGS)
10.3 Point-of-Care Testing
10.4 Artificial Intelligence (AI)
10.5 Other Emerging Techniques
CHAPTER 11 COMPETITIVE LANDSCAPE
11.1 Overview
CHAPTER 12 COMPANY PROFILES
ABBOTT LABORATORIES
BECTON, DICKINSON AND CO.
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
LIST OF TABLES
Summary Table A: Global Market for Clinical Diagnostics, by Type of Test, Through 2028
Summary Table B: Global Market for Clinical Diagnostics, by Region, Through 2028
Table 1: Global Market for Clinical Diagnostics, by Type of Test, Through 2028
Table 2: Global Market for Clinical Diagnostics, by Product Type, Through 2028
Table 3: Global Market for Clinical Diagnostics, by Application, Through 2028
Table 4: Global Market for Clinical Diagnostics, by End User, Through 2028
Table 5: Global Market for Clinical Diagnostics, by Region, Through 2028
Table 6: North American Market for Clinical Diagnostics, by Country, Through 2028
Table 7: European Market for Clinical Diagnostics, by Country, Through 2028
Table 8: Asia-Pacific Market for Clinical Diagnostics, by Country, Through 2028
Table 9: RoW Market for Clinical Diagnostics, by Sub-region, Through 2028
Table 10: Abbott Diagnostics: Product Portfolio
Table 11: Becton, Dickinson and Co.: Company Financials, 2022
Table 12: Becton, Dickinson and Co.: Product Portfolio
Table 13: bioM?rieux SA: Product Portfolio
Table 14: Bio-Rad Laboratories Inc.: Company Financials, 2022
Table 15: Bio-Rad Laboratories Inc.: Product Portfolio
Table 16: Danaher Corp.: Company Financials, 2022
Table 17: Danaher Corp.: Product Portfolio
Table 18: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 19: Qiagen: Product Portfolio
Table 20: Siemens Healthineers AG: Product Portfolio
Summary Table A: Global Market for Clinical Diagnostics, by Type of Test, Through 2028
Summary Table B: Global Market for Clinical Diagnostics, by Region, Through 2028
Table 1: Global Market for Clinical Diagnostics, by Type of Test, Through 2028
Table 2: Global Market for Clinical Diagnostics, by Product Type, Through 2028
Table 3: Global Market for Clinical Diagnostics, by Application, Through 2028
Table 4: Global Market for Clinical Diagnostics, by End User, Through 2028
Table 5: Global Market for Clinical Diagnostics, by Region, Through 2028
Table 6: North American Market for Clinical Diagnostics, by Country, Through 2028
Table 7: European Market for Clinical Diagnostics, by Country, Through 2028
Table 8: Asia-Pacific Market for Clinical Diagnostics, by Country, Through 2028
Table 9: RoW Market for Clinical Diagnostics, by Sub-region, Through 2028
Table 10: Abbott Diagnostics: Product Portfolio
Table 11: Becton, Dickinson and Co.: Company Financials, 2022
Table 12: Becton, Dickinson and Co.: Product Portfolio
Table 13: bioM?rieux SA: Product Portfolio
Table 14: Bio-Rad Laboratories Inc.: Company Financials, 2022
Table 15: Bio-Rad Laboratories Inc.: Product Portfolio
Table 16: Danaher Corp.: Company Financials, 2022
Table 17: Danaher Corp.: Product Portfolio
Table 18: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 19: Qiagen: Product Portfolio
Table 20: Siemens Healthineers AG: Product Portfolio
LIST OF FIGURES
Summary Figure A: Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
Summary Figure B: Global Market for Clinical Diagnostics, by Region, 2020-2028
Figure 1: Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
Figure 2: Global Market for Clinical Diagnostics, by Product Type, 2020-2028
Figure 3: Global Market for Clinical Diagnostics, by Application, 2020-2028
Figure 4: Global Market for Clinical Diagnostics, by End User, 2020-2028
Figure 5: Global Market for Clinical Diagnostics, by Region, 2020-2028
Figure 6: North American Market for Clinical Diagnostics, by Country, 2020-2028
Figure 7: European Market for Clinical Diagnostics, by Country, 2020-2028
Figure 8: Asia-Pacific Market for Clinical Diagnostics, by Country, 2020-2028
Figure 9: RoW Market for Clinical Diagnostics, by Sub-region, 2020-2028
Figure 10: Projected Worldwide Rate of Incidence of Diabetes in Patients Aged 20 to 79 Years, 2010 and 2030
Figure 11: Abbott Laboratories: Diagnostics Division, Net Revenue, 2020-2022
Figure 12: Abbott Diagnostics: Market Share, by Business Segment, 2022
Figure 13: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2022
Figure 14: Becton, Dickinson and Co.: Revenue Share, by Region, 2022
Figure 15: bioM?rieux SA: Net Annual Revenue, 2020-2022
Figure 16: bioM?rieux SA: Market Share, by Application, 2022
Figure 17: Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2022
Figure 18: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
Figure 19: Danaher Corp.: Revenue Share, by Business Segment, 2022
Figure 20: Danaher Corp.: Revenue Share, by Region, 2022
Figure 21: F. Hoffmann-La Roche Ltd.: Diagnostics Division, Net Revenue, 2020-2022
Figure 22: F. Hoffmann-La Roche Ltd.: Diagnostics Division, Market Share, by Customer Area, 2022
Figure 23: Qiagen: Net Revenue, 2020-2022
Figure 24: Qiagen: Market Share, by Product Type, 2022
Figure 25: Siemens Healthineers AG: Net Revenue, 2020-2022
Figure 26: Siemens Healthineers AG: Market Share, by Business Segment, 2022
Figure 27: Thermo Fisher Scientific Inc.: Annual Revenue, 2020-2022
Figure 28: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
Summary Figure A: Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
Summary Figure B: Global Market for Clinical Diagnostics, by Region, 2020-2028
Figure 1: Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
Figure 2: Global Market for Clinical Diagnostics, by Product Type, 2020-2028
Figure 3: Global Market for Clinical Diagnostics, by Application, 2020-2028
Figure 4: Global Market for Clinical Diagnostics, by End User, 2020-2028
Figure 5: Global Market for Clinical Diagnostics, by Region, 2020-2028
Figure 6: North American Market for Clinical Diagnostics, by Country, 2020-2028
Figure 7: European Market for Clinical Diagnostics, by Country, 2020-2028
Figure 8: Asia-Pacific Market for Clinical Diagnostics, by Country, 2020-2028
Figure 9: RoW Market for Clinical Diagnostics, by Sub-region, 2020-2028
Figure 10: Projected Worldwide Rate of Incidence of Diabetes in Patients Aged 20 to 79 Years, 2010 and 2030
Figure 11: Abbott Laboratories: Diagnostics Division, Net Revenue, 2020-2022
Figure 12: Abbott Diagnostics: Market Share, by Business Segment, 2022
Figure 13: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2022
Figure 14: Becton, Dickinson and Co.: Revenue Share, by Region, 2022
Figure 15: bioM?rieux SA: Net Annual Revenue, 2020-2022
Figure 16: bioM?rieux SA: Market Share, by Application, 2022
Figure 17: Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2022
Figure 18: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
Figure 19: Danaher Corp.: Revenue Share, by Business Segment, 2022
Figure 20: Danaher Corp.: Revenue Share, by Region, 2022
Figure 21: F. Hoffmann-La Roche Ltd.: Diagnostics Division, Net Revenue, 2020-2022
Figure 22: F. Hoffmann-La Roche Ltd.: Diagnostics Division, Market Share, by Customer Area, 2022
Figure 23: Qiagen: Net Revenue, 2020-2022
Figure 24: Qiagen: Market Share, by Product Type, 2022
Figure 25: Siemens Healthineers AG: Net Revenue, 2020-2022
Figure 26: Siemens Healthineers AG: Market Share, by Business Segment, 2022
Figure 27: Thermo Fisher Scientific Inc.: Annual Revenue, 2020-2022
Figure 28: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
